PelviTouch for erectile dysfunction and pelvic pain

Many men with erectile dysfunction, urinary incontinence , or pain in the pelvic area look for options other than surgery or injections. PelviTouch is a non-invasive therapy from the Italian company DEKA that uses magnetic fields on the pelvic floor.

Initial data from the company and a small study suggest improvement in pain, some urinary symptoms, and erectile function in certain patients. However, the evidence is still limited and preliminary.

What is PelviTouch and how does it work?

PelviTouch is presented as an option for men with erectile dysfunction, urinary incontinence, and chronic pelvic pain syndrome.

According to DEKA, the goal is to normalize pelvic floor function and optimize erections, thereby improving quality of life for men with intimate problems. The press release also highlights its potential usefulness in stress incontinence following prostatectomy, by strengthening the pelvic floor muscles.

PelviTouch uses TOP FMS (Top Flat Magnetic Stimulation) technology, which generates a homogeneous magnetic field over the pelvic floor. This field acts on the peripheral nerves and causes very intense contractions of the pelvic muscles, greater than voluntary contractions.

According to the company, these repeated contractions strengthen the pelvic floor, and the therapy can also induce muscle relaxation. The aim is to reduce spasms and stiffness in the pelvic area, which can accompany erectile dysfunction, urinary incontinence, and chronic pelvic pain.

What results does the clinical study with this magnetic technology provide?

He study published in the International Journal of Impotence Research analyzes a DEKA device called DR ARNOLD, which uses the same TOP FMS technology described for PelviTouch. It included 20 men with chronic prostatitis syndrome or chronic pelvic pain syndrome.

Patients received eight sessions in an applicator chair. Two sessions were administered per week for four weeks, following a protocol designed to relax muscles and reduce pain.

One month after the end of treatment, pain scores, urinary symptoms, and the impact on quality of life improved significantly. The IIEF-5 questionnaire score also increased, indicating better erectile function in this group. No significant side effects or increased pain were observed during or after the sessions.

The authors emphasize that these are preliminary results, with few patients and no control group, so larger studies and longer follow-ups are needed.

What does the press release say about erectile dysfunction and incontinence?

In the press release, DEKA presents PelviTouch as a new option for men with erectile dysfunction, urinary incontinence, and chronic pelvic pain syndrome. The company states that the therapy strengthens the pelvic floor muscles, helps to optimize erections, and can reduce spasms and stiffness in the area.

According to Professor Nicola Mondaini, quoted in the press release, PelviTouch has shown positive effects in reducing pelvic pain, improving urinary symptoms and quality of life, without the need for invasive or painful procedures.

The company also indicates that the therapy can be helpful in stress incontinence after prostatectomy, by strengthening the pelvic floor and decreasing the frequency and urgency of urination.

What should a patient interested in PelviTouch keep in mind?

Although the initial data with TOP FMS technology is promising, it is still unclear which men benefit the most, how long the effects last, or how it compares to other established treatments.

If you have erectile dysfunction, pelvic pain, or urinary incontinence, talk to a urologist or andrologist. The specialist will assess your case and review the options with you: lifestyle changes, medication, physical therapy, and, if appropriate, pelvic floor magnetic stimulation.

In any case, you should always follow the official instructions for the device and the directions given by your doctor or pharmacist on how to use it. For any treatment decision, the final reference should always be the official product information and the recommendations of healthcare professionals.